Combined Study – Phase 3b MenB Long Term Persistence in Adolescents

Update Il y a 4 ans
Reference: EUCTR2017-000093-11

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

•To assess serum bactericidal activity at approximately 4 to 7.5 years following a 2 dose primary series (persistence) compared to serum bactericidal activity at baseline in vaccination-naïve subjects •To assess and compare the safety and tolerability of a single dose (booster) of rMenB+OMV NZ administered to follow-on subjects approximately 4 to 7.5 years after a 2 dose primary series.


Inclusion criteria

  • Healthy volunteers (Infections, Meningococcal)

Links